GB2607558.0 — Filed 1 April 2026 — RAPIDHealth Longevity & Beauty Track
RAPID
LONGEVITY.
The ocean has been making this for free for millions of years. Nobody could access it. Until now.
The Core Science
SIRT6.
THE LONGEVITY SWITCH.
SIRT6 is a NAD+-dependent deacylase with dual activity — deacetylation and mono-ADP-ribosylation. It is one of the most studied longevity proteins in biology. It regulates DNA repair, telomere maintenance, metabolic homeostasis, and the inflammatory SASP that drives biological ageing.
The Rochester study demonstrated +13% median mouse lifespan with SIRT6 activation using thermally extracted fucoidan. That study used the degraded compound. Native-sulphation fucoidan — the compound RAPIDLongevity is built around — interacts directly with SIRT6 via sulphate ester groups that thermal processing destroys. The native-sulphation comparison has not yet been run. The +13% figure is a lower bound.
University of York Centre for Novel Agricultural Products — in discussion regarding comparative sulphation characterisation study
GB2607558.0 — Mechanisms
FOUR
PATHWAYS.
SIRT6 Activation
Native fucoidan sulphate esters — direct SIRT6 bindingNative-sulphation fucoidan sulphate ester groups bind directly to SIRT6, activating both deacetylation and mono-ADP-ribosylation activity. The binding mechanism is sulphation-dependent — thermal processing destroys the sulphate ester groups that drive the interaction. Every commercial fucoidan supplement on the market is built around the wrong compound.
Senomorphic Activity
NF-κB suppression · Nrf2 activation · Dual-pathway SASP reductionTwo simultaneous anti-senescence mechanisms. Fucoidan suppresses NF-κB/COX-2 inflammatory signalling — reducing the SASP cytokine cascade that drives tissue ageing. Intact phlorotannins activate Nrf2 antioxidant response — reducing the oxidative stress that accelerates cellular senescence. Both pathways suppressed simultaneously. IL-6, IL-8, and MCP-1 reduction is the measurable outcome.
Hair Follicle Senescence Reversal
Wnt/β-catenin · VEGF promotion · SIRT6 stem cell senescenceThree simultaneous follicle mechanisms. Wnt/β-catenin activation extends the anagen (growth) phase of the hair cycle. VEGF promotion drives dermal papilla vascularisation, improving nutrient delivery to the follicle. SIRT6-mediated reduction of follicle stem cell senescence restores the regenerative capacity that ageing progressively depletes. Three delivery formats: topical, oral, injectable. Indications: androgenetic alopecia, chemotherapy-induced alopecia, age-related thinning.
Skin Anti-Ageing
Fibroblast proliferation · NF-κB suppression · SIRT6 DNA repair in skin cellsThis is not a topical delivery mechanism — it is systemic. Fucoidan drives fibroblast proliferation, increasing dermal collagen production from within. NF-κB suppression in skin cells reduces the chronic low-grade inflammation that drives photoageing and loss of dermal architecture. SIRT6 activation in skin fibroblasts improves DNA repair fidelity, reducing the accumulation of somatic mutations that degrade skin cell function over time.
Rochester study — SIRT6 activation — thermally extracted fucoidan — lower bound
+13%
Median mouse lifespan increase — native-sulphation experiment not yet run — the number that matters has not been measured yet
Commercial Applications
THREE
MARKETS.
One compound profile. Three commercial tracks. Supplement. Luxury cosmetics. Precision medicine. Not sold direct to consumers — licensing partnerships only.
Longevity Supplements
Oral capsule · Powder · Liquid extractSIRT6 activation, senomorphic activity, systemic anti-ageing. The DoNotAge and Elysium markets already sell fucoidan supplements on a SIRT6 mechanism thesis — using thermally extracted material. Their own published science states native sulphation is the critical variable. The supply upgrade is the product.
Luxury Cosmetics
Topical · Injectable · Functional ingredientHair follicle senescence reversal. Skin anti-ageing via fibroblast proliferation and SIRT6 DNA repair. Intact phlorotannins — Nrf2 antioxidant activation. A single ingredient with a multi-mechanism story that no competitor can source. The Bio-Farm cold-processing chain is the moat. LVMH Recherche is the primary licensing target.
Precision Medicine
Injectable · Oral · Systemic deliverySIRT6-mediated senescence suppression, SASP reduction, and VEGF-driven tissue vascularisation as functional therapeutics. Chemotherapy-induced alopecia as a validated clinical indication for hair follicle senescence reversal. Systemic skin anti-ageing via dermatology channel. Oncology support via cachexia mechanism overlap with RAPIDOncology track.
Licensing Partnerships
SEEKING
LICENSEES.
Not sold direct to consumers. Seeking ingredient licensing and co-development partnerships across supplement, luxury cosmetics, and precision medicine channels.
LVMH Recherche
Luxury cosmetics — primary targetHair follicle senescence reversal + skin anti-ageing + SIRT6 activation in a single ingredient. No cold chain for finished formulation. A multi-mechanism longevity story that no existing cosmeceutical ingredient can match. Supply chain moated by the Bio-Farm processing chain — no competitor can source the same compound.
DoNotAge
Supplement — supply upgradeDoNotAge already sells a fucoidan-based SIRT6 supplement using thermally extracted material. Their own published science states native sulphation is critical for SIRT6 interaction. The native-sulphation supply upgrade is the product. The Rochester +13% data is on their existing compound. The native comparison has not been run.
Elysium Health
Supplement — longevity scienceElysium's positioning is science-led longevity supplementation. Native-sulphation fucoidan adds SIRT6 activation, senomorphic activity, and SASP suppression to their stack — mechanisms that align directly with their published science programme and their academic advisory model.
GB2607558.0 — Filed 1 April 2026
INGREDIENT LICENSING
ENQUIRIES WELCOME
Full mechanism data, comparative sulphation analysis framework, and licensing terms available under NDA. University of York comparative study in discussion.